Company / Gross Margin
Silo Pharma, Inc. Gross Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
91.9%
FY2025
5-year range
32.5% / 91.9%
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
91.9% in FY2025 with a 5-year CAGR of +59.4%.
Remained stable around 91.9% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- +59.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, gross margin increased 0.0% year-over-year.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 91.9% | +0.0% |
| FY2024 | 91.9% | +0.0% |
| FY2023 | 91.9% | +182.9% |
| FY2020 | 32.5% | +0.0% |
| FY2019 | 32.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026